| scholarly article | Q13442814 |
| P50 | author | Terry Fredeking | Q83773246 |
| P2093 | author name string | C Perez-Osorio | |
| I Vado-Solis | |||
| J E Z Castro | |||
| P2860 | cites work | Human malarial disease: a consequence of inflammatory cytokine release | Q21034098 |
| Changes in immune parameters and their correction in human cases of tick-borne encephalitis | Q27478107 | ||
| Combinatorial Computational Approaches to Identify Tetracycline Derivatives as Flavivirus Inhibitors | Q27478304 | ||
| Multiplex cytokine profile from dengue patients: MIP-1beta and IFN-gamma as predictive factors for severity | Q27486434 | ||
| Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody F(ab')2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels | Q28301776 | ||
| Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century | Q29616264 | ||
| Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza A/H5N1 virus | Q30482353 | ||
| The role of cytokines in activation of coagulation and fibrinolysis in dengue shock syndrome | Q30817043 | ||
| Should tetracycline treatment be used more extensively for rheumatoid arthritis? Metaanalysis demonstrates clinical benefit with reduction in disease activity. | Q33193663 | ||
| The clinical response to minocycline in multiple sclerosis is accompanied by beneficial immune changes: a pilot study | Q34623345 | ||
| Dengue and dengue hemorrhagic fever in the Americas: lessons and challenges | Q35119777 | ||
| Anti-cytokine therapeutics and infections | Q35134693 | ||
| High levels of interleukin 10 in serum are associated with fatality in meningococcal disease. | Q35414992 | ||
| Viral hemorrhagic fevers | Q36525319 | ||
| Of cascades and perfect storms: the immunopathogenesis of dengue haemorrhagic fever-dengue shock syndrome (DHF/DSS). | Q36666340 | ||
| Many cytokines are very useful therapeutic targets in disease | Q37316591 | ||
| Anti-cytokine therapeutics: history and update | Q37515918 | ||
| Immunomodulatory properties of antibiotics | Q37659061 | ||
| Pathophysiologic and prognostic role of cytokines in dengue hemorrhagic fever | Q38906764 | ||
| Hypoxia-activated microglial mediators of neuronal survival are differentially regulated by tetracyclines | Q40303844 | ||
| The biological properties of interleukin-1. | Q40512140 | ||
| Serum levels of tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), and interleukin-1 beta (IL-1 beta) in dengue-infected patients. | Q40720407 | ||
| Imbalance between tumour necrosis factor-alpha and soluble TNF receptor concentrations in severe meningococcaemia. The J5 Study Group | Q41084831 | ||
| Neuroprotection in Huntington's disease: a 2-year study on minocycline | Q45108539 | ||
| Increased soluble interleukin-1 type II receptor concentrations in postoperative patients and in patients with sepsis syndrome. | Q50165869 | ||
| Anti-inflammatory cytokine profile and mortality in febrile patients. | Q50866885 | ||
| Cutting edge: mechanism of enhancement of in vivo cytokine effects by anti-cytokine monoclonal antibodies. | Q53509521 | ||
| Early Immune Activation in Acute Dengue Illness Is Related to Development of Plasma Leakage and Disease Severity | Q56995364 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | dengue fever | Q30953 |
| tetracycline | Q193045 | ||
| doxycycline | Q422442 | ||
| Dengue virus | Q476209 | ||
| P304 | page(s) | 370872 | |
| P577 | publication date | 2011-03-28 | |
| P1433 | published in | Clinical and Developmental Immunology | Q15754140 |
| P1476 | title | Modulation of cytokine and cytokine receptor/antagonist by treatment with doxycycline and tetracycline in patients with dengue fever | |
| P478 | volume | 2011 |
| Q40096031 | Association of genetic polymorphisms of IL1β -511 C>T, IL1RN VNTR 86 bp, IL6 -174 G>C, IL10 -819 C>T and TNFα -308 G>A, involved in symptomatic patients with dengue in Brazil |
| Q40061338 | Case Management of Dengue: Lessons Learned |
| Q33552896 | Current Status of Dengue Therapeutics Research and Development |
| Q38765172 | Current and future developments in the treatment of virus-induced hypercytokinemia. |
| Q38992396 | Current management of severe dengue infection |
| Q85327578 | Dengue |
| Q28542607 | Dengue therapeutics, chemoprophylaxis, and allied tools: state of the art and future directions |
| Q50041817 | Doxycycline inhibits experimental cerebral malaria by reducing inflammatory immune reactions and tissue-degrading mediators |
| Q45353001 | Drug-induced severe adverse reaction enhanced by human herpes virus-6 reactivation |
| Q38870485 | Investigational drugs in early development for treating dengue infection. |
| Q39251976 | Minocycline modulates cytokine and chemokine production in lipopolysaccharide-stimulated THP-1 monocytic cells by inhibiting IκB kinase α/β phosphorylation |
| Q91887815 | Novel anti-flavivirus drugs targeting the nucleolar distribution of core protein |
| Q26862449 | Novel approaches and challenges to treatment of central nervous system viral infections |
| Q47143816 | Tetracyclines downregulate the production of LPS-induced cytokines and chemokines in THP-1 cells via ERK, p38, and nuclear factor-κB signaling pathways |
| Q27523270 | The flavivirus capsid protein: Structure, function and perspectives towards drug design |
| Q40110514 | Transcriptome profiling reveals differential expression of interferon family induced by dengue virus 2 in human endothelial cells on tissue culture plastic and polyacrylamide hydrogel |
Search more.